Bio Rad
Bio-Rad Laboratories, Inc., a leading global provider of life science research and clinical diagnostics products, is headquartered in the United States. Founded in 1952, the company has established itself as a key player in the biotechnology industry, with significant operations across North America, Europe, and Asia. Bio-Rad's core offerings include a diverse range of products such as reagents, instruments, and software for research and clinical applications. Their innovative solutions, particularly in the fields of genomics, proteomics, and quality control, set them apart in a competitive market. Notably, Bio-Rad has achieved recognition for its commitment to advancing scientific discovery and improving healthcare outcomes. With a strong market position, Bio-Rad continues to drive progress in the life sciences sector, underscoring its role as a trusted partner for researchers and clinicians worldwide.
DitchCarbon Score
How does Bio Rad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio Rad's score of 37 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio Rad's reported carbon emissions
In 2023, Bio-Rad Laboratories, Inc. reported total carbon emissions of approximately 24,483,000 kg CO2e, with 13,920,000 kg CO2e attributed to Scope 2 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 46% reduction in Scope 1 and 2 emissions by 2030, using 2019 as the baseline year. This commitment reflects a proactive approach to climate action, aligning with industry standards for sustainability. In 2022, Bio-Rad's emissions included 21,216,000 kg CO2e from Scope 1 and 16,813,000 kg CO2e from Scope 2, alongside significant Scope 3 emissions of 295,930,000 kg CO2e, which encompass indirect emissions from the supply chain and product use. The company is actively working to address these emissions through its sustainability initiatives. Bio-Rad's climate commitments are not cascaded from a parent organization, indicating a direct responsibility for its emissions data and reduction targets. The company is focused on enhancing its sustainability practices and reducing its overall environmental impact, demonstrating leadership in the life sciences industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 18,420,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 13,615,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 314,454,000 | 000,000,000 | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bio Rad is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
